1. Describe, explain, categorise the following with respect to transfusion in surgery, and evaluate and recommend management strategies fora. Pre-operative assessment including anaemia and coagulation
problemsb. Cell salvage and blood sparing surgeryc. Acute bleedingd. Post-operative transfusion thresholdse. Cardiac surgery and bypass2. Describe, explain, categorise the routine and/ or restrictive use of red cell/ platelets/ plasma with respect to transfusion in critically ill patients. Evaluate and explain transfusion triggers and threshold; recommend management strategies
3. Describe and explain the following with regard to major haemorrhage for a range of different patient groupsa. The physiology of shock and trauma induced coagulopathyb. The acute management of major haemorrhage including
pharmacological treatments and transfusion managementc. The use of near patient testing in major haemorrhaged. Emergency transfusion outside the hospital setting and selection of
appropriate blood components4. Evaluate and recommend transfusion management strategies for a range of inherited haemoglobinopathies.
5. Determine and explain the problems associated with chronic transfusion such as iron overload in haematological diseases
6. Describe, evaluate and recommend strategies for transfusion management of patients with warm and cold auto-immune haemolytic anaemia, autoimmune thrombocytopenic purpura (AITP) bleeding, thrombotic thrombocytopenic purpura (TTP), haemolytic uremic syndrome (HUS), microangiopathic haemolytic anaemia (MAHA)
7. Describe, explain, categorise the use of blood components in cancer (oncology and leukaemia) patients with respect to red cells, platelets, granulocytes. Evaluate specific transfusion triggers/ thresholds and beneficial effects of transfusion. Recommend management strategies including recommendations for resolving transfusion-associated problems/ adverse effects of transfusion and alternatives to transfusion
8. Outline, describe, explain, and categorise anaemias and haematological disease occurring in pregnancy (including HELLP, TTP, and SCD). Describe, evaluate and recommend strategies for their management
9. Determine, describe, explain and investigate the features and cause of, and problems associated with, obstetric massive transfusion, antepartum haemorrhage and postpartum haemorrhage. Outline, explain and evaluate treatment options including use of blood components
10. Outline, describe and explain the causes and effect of haemolytic disease of the fetus/ newborn (HDFN). Describe, evaluate and recommend strategies for clinical management of women with clinically significant red cell antibodies in pregnancy, and of the affected fetus/neonate including intrauterine and exchange transfusion
11. Determine, describe and explain the design, operation and performance of anti-D Ig prophylaxis for the prevention of immune anti-D formation in D negative females
12. Describe, categorise and explain the particular management and administration of blood component transfusion in children including neonatal transfusion and differing stages of prematurity
13. Explain and categorise the principles and practice of transfusion support in haemopoietic stem cell and solid organ transplantation patients including pre-, peri-/ ‘during’, post-treatment management and guidelines
This site uses cookies that enable us to make improvements, provide relevant content, and for analytics purposes. For more details, see our Cookie Policy. By clicking Accept, you consent to our use of cookies.